When evaluating the risk for cervical cancer associated with the COMT genotypes, we observed that the best model was the COMT LL genotype, which could represent up to 5 times more risk (OR = 4.83, 95% CI = 2.08–11.20, p < 0.001). This evidence concerns the gene COMT and cervical carcinoma.